Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8572505rdf:typepubmed:Citationlld:pubmed
pubmed-article:8572505lifeskim:mentionsumls-concept:C0004927lld:lifeskim
pubmed-article:8572505lifeskim:mentionsumls-concept:C0024002lld:lifeskim
pubmed-article:8572505lifeskim:mentionsumls-concept:C0029997lld:lifeskim
pubmed-article:8572505lifeskim:mentionsumls-concept:C0699900lld:lifeskim
pubmed-article:8572505lifeskim:mentionsumls-concept:C0243125lld:lifeskim
pubmed-article:8572505lifeskim:mentionsumls-concept:C1514468lld:lifeskim
pubmed-article:8572505lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:8572505pubmed:issue6lld:pubmed
pubmed-article:8572505pubmed:dateCreated1996-3-6lld:pubmed
pubmed-article:8572505pubmed:abstractTextLorazepam and oxazepam are benzodiazepine which differ by the presence, or not, of chlorine atom on the phenyl ring. These molecules are able of chemical and thermal degradation with water intramolecular elimination between hydroxy and amine functional group and formation of carboxaldehyde quinazoline. These substances characterise lorazepam and oxazepam by their thermal behaviour and melting temperature by heating and cooling cycles.lld:pubmed
pubmed-article:8572505pubmed:languagefrelld:pubmed
pubmed-article:8572505pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8572505pubmed:citationSubsetIMlld:pubmed
pubmed-article:8572505pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8572505pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8572505pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8572505pubmed:statusMEDLINElld:pubmed
pubmed-article:8572505pubmed:issn0003-4509lld:pubmed
pubmed-article:8572505pubmed:authorpubmed-author:ChauvetAAlld:pubmed
pubmed-article:8572505pubmed:issnTypePrintlld:pubmed
pubmed-article:8572505pubmed:volume53lld:pubmed
pubmed-article:8572505pubmed:ownerNLMlld:pubmed
pubmed-article:8572505pubmed:authorsCompleteYlld:pubmed
pubmed-article:8572505pubmed:pagination256-60lld:pubmed
pubmed-article:8572505pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:8572505pubmed:meshHeadingpubmed-meshheading:8572505-...lld:pubmed
pubmed-article:8572505pubmed:meshHeadingpubmed-meshheading:8572505-...lld:pubmed
pubmed-article:8572505pubmed:meshHeadingpubmed-meshheading:8572505-...lld:pubmed
pubmed-article:8572505pubmed:meshHeadingpubmed-meshheading:8572505-...lld:pubmed
pubmed-article:8572505pubmed:meshHeadingpubmed-meshheading:8572505-...lld:pubmed
pubmed-article:8572505pubmed:meshHeadingpubmed-meshheading:8572505-...lld:pubmed
pubmed-article:8572505pubmed:year1995lld:pubmed
pubmed-article:8572505pubmed:articleTitle[Characterization of lorazepam and oxazepam by the thermal behavior of their degradation product].lld:pubmed
pubmed-article:8572505pubmed:affiliationFaculté de Pharmacie, Laboratoire de Chimie Générale et Minérale, Montpellier.lld:pubmed
pubmed-article:8572505pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8572505pubmed:publicationTypeEnglish Abstractlld:pubmed